11-108304829-CA-CAA
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.5653dupA(p.Thr1885AsnfsTer19) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.5653dupA | p.Thr1885AsnfsTer19 | frameshift_variant | Exon 37 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Thr1885Asnfs*19) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 418036). -
not provided Pathogenic:1
This duplication of one nucleotide in ATM is denoted c.5653dupA at the cDNA level and p.Thr1885AsnfsX19 (T1885NfsX19) at the protein level. Using alternate nomenclature, this variant would be defined as ATM 5652dupA. The normal sequence, with the base that is duplicated in brackets, is CACA[dupA]CCCCT. The duplication causes a frameshift, which changes a Threonine to an Asparagine at codon 1885 and creates a premature stop codon at position 19 of the new reading frame. Although this variant has not, to our knowledge, been reported in the literature, it is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. We consider this variant to be pathogenic. -
Familial cancer of breast Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
Hereditary breast ovarian cancer syndrome Pathogenic:1
This sequence variant is a single nucleotide duplication (dupA) in exon 37/63 of the ATM gene and results in an early termination codon 19 amino acids downstream of the frameshift at Thr1885. This variant is predicted to generate a non-functional allele through either the expression of a truncated protein, or a loss of ATM expression due to nonsense mediated decay. This is a previously reported variant (ClinVar) that is absent in control population datasets (ExAC, gnomAD databases) and has not been reported in breast cancer patients in the published literature, to our knowledge. Haploinsufficiency of ATM is a known cause of increased breast cancer risk (PMID 10677309). Thus, we consider this variant to be pathogenic. -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at